Sophie Pierce is determined to make the most of her life - however long she may have.

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display ... Landmark Study Involving Babies in Ireland Supports Use of Cystic Fibrosis Drug in ...

There was severe flooding in the Mid-Ohio Valley at the beginning of April that caused some businesses to go underwater. Two ...

Vertex has won two cystic fibrosis approvals from the FDA, but the agency included high-level safety warnings.

Whether you are dealing with severe consequences of cystic fibrosis or want to get ahead the symptoms, these tips will help.

Navocaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

LCI proves valuable in monitoring ETI therapy effectiveness for cystic fibrosis patients with minimal FEV1 changes, detecting ...

Stockard has completed the interview portion of the competition and is now preparing for on-stage competition, which, for her, begins Wednesday.

SION-2851 is under development for the treatment of cystic fibrosis. It is a small molecule administered orally. It is a first generation corrector. The drug candidate targets cystic fibrosis ...